Laurie J. Hall Trustee’s Cartesian Therapeutics RNAC Stock Holding History

Laurie J. Hall Trustee’s Portfolio RNAC Stock Details RNAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,759	Closed	-$32K	–	213
2024 Q4	$32K	Hold	1,759	–	–	0.01%	204
2024 Q3	$28K	Hold	1,759	–	–	0.01%	217
2024 Q2	$48K	Hold	1,759	–	–	0.02%	178
2024 Q1	$34K	Hold	1,759	–	–	0.01%	195
2023 Q4	$36K	Hold	1,759	–	–	0.01%	190
2023 Q3	$56K	Hold	1,759	–	–	0.02%	163
2023 Q2	$59K	Hold	1,759	–	–	0.02%	165
2023 Q1	$73K	Hold	1,759	–	–	0.03%	155
2022 Q4	$60K	Hold	1,759	–	–	0.03%	156
2022 Q3	$87K	Hold	1,759	–	–	0.04%	139
2022 Q2	$69K	Hold	1,759	–	–	0.03%	156
2022 Q1	$65K	Hold	1,759	–	–	0.03%	170
2021 Q4	$172K	Hold	1,759	–	–	0.06%	123
2021 Q3	$220K	Hold	1,759	–	–	0.08%	106
2021 Q2	$0	Hold	1,759	–	–	﹤0.01%	328
2021 Q1	$0	Hold	1,759	–	–	﹤0.01%	345
2020 Q4	$0	Buy	+1,759	New	+$153K	﹤0.01%	344

Other funds holding RNAC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Laurie J. Hall Trustee's RNAC Position: Q1 2025 in Review

Laurie J. Hall Trustee sold out of Cartesian Therapeutics (RNAC) in Q1 2025, closing a stake of 1,759 shares — an estimated $32K sold.

Laurie J. Hall Trustee first reported a position in RNAC in Q4 2020 and held it in 17 quarters. The position peaked at $220K in Q3 2021. 72 funds tracked by Wall St. Rank hold RNAC as of Q1 2025.

Laurie J. Hall Trustee reported no remaining Cartesian Therapeutics position as of Q1 2025 after selling out during the quarter.
Laurie J. Hall Trustee sold 1,759 Cartesian Therapeutics shares in Q1 2025, an estimated $32K.
Laurie J. Hall Trustee first reported a position in Cartesian Therapeutics in Q4 2020 and held it in 17 quarters.
Laurie J. Hall Trustee's Cartesian Therapeutics position peaked at $220K in Q3 2021.
72 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2025.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2025, filed 15 May 2025.